We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$578B
AUM Growth
+$59.6B
Cap. Flow
+$35.2B
Cap. Flow %
6.08%
Top 10 Hldgs %
31.21%
Holding
15,826
New
1,745
Increased
6,428
Reduced
6,082
Closed
1,423

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$830M
2
UNH icon
UnitedHealth
UNH
+$769M
3
AJG icon
Arthur J. Gallagher & Co
AJG
+$691M
4
AMZN icon
Amazon
AMZN
+$654M
5
BAC icon
Bank of America
BAC
+$634M

Sector Composition

Rank Sector Weight
1 Healthcare 3.13%
2 Technology 2.97%
3 Financials 2.19%
4 Consumer Discretionary 2.09%
5 Industrials 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XHR
13701
PUT
Xenia Hotels & Resorts
XHR
$1.77B
$7.43K ﹤0.01%
+500
New +$7.56K
EWZS icon
13702
CALL
iShares MSCI Brazil Small-Cap ETF
EWZS
$205M
$7.4K ﹤0.01%
800
-4,000
-83% -$45.1K
IRIX icon
13703
PUT
IRIDEX
IRIX
$14.9M
$7.39K ﹤0.01%
4,400
-3,400
-44% -$5.61K
LPAAW
13704
Launch One Acquisition Corp Warrant
LPAAW
$1.9M
$7.35K ﹤0.01%
54,467
-699
-1% -$67
CCBG icon
13705
PUT
Capital City Bank Group
CCBG
$898M
$7.33K ﹤0.01%
200
-200
-50% -$7.38K
XAIR icon
13706
CALL
Beyond Air
XAIR
$5.61M
$7.31K ﹤0.01%
51
+1
+2% +$179
BNGO icon
13707
PUT
Bionano Genomics
BNGO
$13.5M
$7.25K ﹤0.01%
419
-307
-42% -$5.25K
HOOK
13708
CALL
DELISTED
HOOKIPA Pharma
HOOK
$7.24K ﹤0.01%
3,600
+1,220
+51% +$3.77K
NBBK icon
13709
PUT
NB Bancorp
NBBK
$1.01B
$7.22K ﹤0.01%
400
AAXJ icon
13710
CALL
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.84B
$7.22K ﹤0.01%
+100
New +$7.6K
INZY
13711
CALL
DELISTED
Inozyme Pharma
INZY
$7.2K ﹤0.01%
2,600
-1,100
-30% -$4.18K
CVGI icon
13712
PUT
Commercial Vehicle Group
CVGI
$132M
$7.19K ﹤0.01%
2,900
-4,300
-60% -$11.5K
ABEO icon
13713
Abeona Therapeutics
ABEO
$341M
$7.14K ﹤0.01%
1,282
+573
+81% +$3.53K
AIP icon
13714
PUT
Arteris
AIP
$1.39B
$7.13K ﹤0.01%
700
-4,600
-87% -$38K
BMRC icon
13715
CALL
Bank of Marin Bancorp
BMRC
$458M
$7.13K ﹤0.01%
300
+100
+50% +$2.36K
PMCB icon
13716
PUT
PharmaCyte Biotech
PMCB
$5.92M
$7.13K ﹤0.01%
+4,600
New +$7.94K
GURE
13717
Gulf Resources
GURE
$4.63M
$7.13K ﹤0.01%
+1,261
New +$8.63K
HAFC icon
13718
PUT
Hanmi Financial
HAFC
$962M
$7.09K ﹤0.01%
300
DLNG icon
13719
PUT
Dynagas LNG Partners
DLNG
$140M
$7.07K ﹤0.01%
+1,300
New +$5.55K
EFAV icon
13720
PUT
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.48B
$7.07K ﹤0.01%
+100
New +$7.36K
ATXG icon
13721
Addentax Group
ATXG
$4.28M
$7.06K ﹤0.01%
+768
New +$7.35K
YMAB
13722
PUT
DELISTED
Y-mAbs Therapeutics
YMAB
$7.05K ﹤0.01%
900
+500
+125% +$6.09K
GRSD
13723
PUT
Grandstand Limited Ordinary Shares
GRSD
$80.4M
$7.04K ﹤0.01%
500
-2,700
-84% -$31.8K
NRSNW icon
13724
NeuroSense Therapeutics Warrant
NRSNW
$7.04K ﹤0.01%
22,711
-2,563
-10% -$685
ACET icon
13725
CALL
Adicet Bio
ACET
$78.4M
$7.02K ﹤0.01%
456
+193
+73% +$3.64K

Similar funds

Citadel Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.

  • Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
  • Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
  • Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
  • Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
  • Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.